Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
NKGen Biotech (NKGN) has issued an announcement.
Pierre Gagnon has stepped down from his role as Chief Operating Officer of NKGen Biotech, Inc., effective immediately, though there is no indication that his resignation is due to disagreements with the company’s operations or practices. Gagnon will remain involved with the company in a non-executive capacity to offer transition and advisory services until the end of November 2024. The company cautions that its forward-looking statements in the report carry risks and uncertainties, advising investors not to rely too heavily on them as they are based on current expectations which are subject to change.
Learn more about NKGN stock on TipRanks’ Stock Analysis page.
